Indian Cancer Congress - wonderful meeting but made me feel that corporate players are taking over oncology diagnostics and testing in India while institutes are left unsupported. Is this really advance ?
Patients are th source of knowledge and infrastructure around it is a win win situation. MCI has made IHC compulsory for md path but most insitutes are not using this to upgrade themselves
Superb session on Hodgkin lymphoma by @TanujaShet … pragmatic approach , different faces of HRS cells , mimics ,and great discussion on the differential diagnosis .. – at Cuttack, India